📋 Product Overview Table
| 🌐 Specification | 🧾 Details |
|---|---|
| 💊 Active Ingredient | Cabergoline 0.25mg |
| 🧪 Formulation | Dopamine Agonist Tablet |
| 🏭 Manufacturer | Sun Pharmaceutical Industries Ltd |
| 💊 Dosage Form | Oral Tablet |
| 📦 Packaging | 4 Tablets in 1 Strip |
| 🩺 Indication | Hyperprolactinemia, pituitary tumors, Parkinson’s disease (off-label) |
| 🇺🇸 US Brand Equivalent | Dostinex (by Pfizer) |
| ⏱️ Delivery Time | 6 to 15 days |
🧬 Introduction – What is Cabgolin 0.25mg (Cabergoline)?
Cabgolin 0.25mg contains Cabergoline, a potent dopamine D2 receptor agonist, prescribed mainly to treat hyperprolactinemia — a condition where the body produces excess prolactin hormone, often leading to menstrual disturbances, infertility, or milk secretion in non-lactating women.
Manufactured by Sun Pharmaceutical Industries Ltd, one of India’s largest and most reputable pharmaceutical companies, Cabgolin is a widely trusted and cost-effective alternative to branded equivalents like Dostinex by Pfizer.
Cabergoline works by mimicking dopamine, the brain chemical that naturally inhibits prolactin production. This allows normalization of hormone levels, restoration of ovulation, improved fertility, and reduction of tumor size in prolactinomas. It’s also used off-label in the treatment of Parkinson’s disease and other dopamine-related disorders due to its strong dopaminergic action.
With fewer gastrointestinal side effects and a longer half-life compared to bromocriptine, Cabgolin has become a first-line agent in managing prolactin disorders in both men and women.
🎥 Video Overview – Understanding Cabgolin
📺 “Cabergoline Explained: Restoring Hormonal Balance“
🎬 Video Placeholder – Overview of mechanism, uses in fertility, and treatment timeline.
Always take Cabgolin under medical supervision. Do not self-medicate or adjust dosage without guidance.
🔬 Pharmacological Profile
| 🧪 Parameter | 📊 Details |
|---|---|
| Drug Class | Dopamine D2 Receptor Agonist |
| Mechanism | Inhibits prolactin secretion from the anterior pituitary |
| Bioavailability | ~60% |
| Onset of Action | Within 3 hours |
| Elimination Half-Life | ~63–69 hours |
| Metabolism | Hepatic |
| Excretion | Feces (~60%), Urine (~22%) |
💡 Dosing Guidelines
| 🗓️ Condition | 💊 Typical Dose |
|---|---|
| Hyperprolactinemia | 0.25mg twice weekly (initial), adjust per response |
| Pituitary Adenomas | Up to 1mg twice weekly (under supervision) |
| Parkinson’s Disease (off-label) | 0.5–3mg/day (titrated individually) |
Doses may be increased gradually based on prolactin levels. Take with food to minimize nausea.
⚠️ Side Effects & Warnings
| 💥 Common Side Effects | ❗ Serious Side Effects (Rare) |
|---|---|
| Nausea, dizziness | Cardiac valvulopathy, pulmonary fibrosis |
| Constipation, fatigue | Hallucinations, impulse control disorders |
| Headache, nasal congestion | Orthostatic hypotension |
Precautions: Avoid in patients with uncontrolled hypertension, history of heart valve issues, or fibrotic disorders.
🧃 Storage Guidelines
- Store below 25°C (77°F)
- Protect from light and moisture
- Keep out of reach of children
🌍 Global Availability & Import Rules
| 🌎 Country | 📦 Import Status | 📋 Prescription Requirement |
|---|---|---|
| 🇺🇸 USA | Permitted via FDA personal import policy | Yes |
| 🇬🇧 UK | Allowed under MHRA regulations | Yes |
| 🇦🇺 Australia | TGA allows with valid prescription | Yes |
🔗 Related Hormonal Therapies (Internal Links)
| 💊 Product Name | 🏭 Manufacturer | 📖 Description |
|---|---|---|
| Dostinex 0.5mg | Pfizer Inc. | Brand-name Cabergoline used worldwide for prolactin disorders |
| Bromopil 2.5mg | Intas Pharma | Bromocriptine-based therapy for hyperprolactinemia and Parkinson’s disease |
| Caberdost 0.5mg | Sun Pharma | Higher strength Cabergoline for titrated therapy |
| Cabermax 0.5mg | Johnlee Pharma | Alternative dopamine agonist tablet for pituitary regulation |
| Proctinal 2.5mg | GlaxoSmithKline | Popular bromocriptine formulation used in hormonal regulation |
📚 Authoritative References
- FDA – Cabergoline Label
- Drugs.com – Cabergoline
- NHS – Prolactin Disorders
- PubMed – Clinical Use of Cabergoline
- Sun Pharma Official Site
🩺 Endocrinologist’s Review – Dr. Meera Nair, MD (Endocrinology)
“Cabgolin is my preferred choice in managing prolactin excess due to its long half-life, minimal dosing frequency, and excellent tolerability. For many patients, it restores hormonal balance and improves reproductive outcomes effectively.”
⚠️ Disclaimer
This article is for informational purposes only. Always consult a certified healthcare provider before starting or adjusting any medication including Cabgolin (Cabergoline).

